POLYMED Share Price Target 2050

CAGR-based price projection for Poly Medicure Limited (POLYMED) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (4.8% CAGR)
Rs 5,057
2050 Target
Base Case (12.0% CAGR)
Rs 24,982
2050 Target
Bull Case (33.1% CAGR)
Rs 1,575,701
2050 Target

Current Market Snapshot

CMP: Rs 1,638.10
52W High: Rs 1,869.40
52W Low: Rs 1,321.40
1Y CAGR: 25.5%
3Y CAGR: 12.0%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,717 Rs 1,835 Rs 2,181
2028 Rs 1,799 Rs 2,056 Rs 2,904
2029 Rs 1,886 Rs 2,303 Rs 3,866
2030 Rs 1,977 Rs 2,580 Rs 5,147
2031 Rs 2,072 Rs 2,890 Rs 6,852
2032 Rs 2,171 Rs 3,237 Rs 9,123
2033 Rs 2,276 Rs 3,626 Rs 12,146
2034 Rs 2,385 Rs 4,062 Rs 16,170
2035 Rs 2,500 Rs 4,551 Rs 21,529
2036 Rs 2,620 Rs 5,098 Rs 28,662
2037 Rs 2,746 Rs 5,711 Rs 38,160
2038 Rs 2,878 Rs 6,397 Rs 50,805
2039 Rs 3,017 Rs 7,166 Rs 67,640
2040 Rs 3,162 Rs 8,028 Rs 90,054
2041 Rs 3,314 Rs 8,993 Rs 119,894
2042 Rs 3,473 Rs 10,074 Rs 159,623
2043 Rs 3,640 Rs 11,285 Rs 212,517
2044 Rs 3,815 Rs 12,642 Rs 282,937
2045 Rs 3,999 Rs 14,162 Rs 376,693
2046 Rs 4,191 Rs 15,864 Rs 501,516
2047 Rs 4,392 Rs 17,771 Rs 667,701
2048 Rs 4,604 Rs 19,908 Rs 888,954
2049 Rs 4,825 Rs 22,301 Rs 1,183,523
2050 Rs 5,057 Rs 24,982 Rs 1,575,701

Other POLYMED Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the POLYMED share price target for 2050?

Based on historical growth analysis, the POLYMED share price target for 2050 ranges from Rs 5,057 (conservative) to Rs 24,982 (base case) to Rs 1,575,701 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of POLYMED?

The current market price of POLYMED (Poly Medicure Limited) is Rs 1,638.10. The 52-week high is Rs 1,869.40 and 52-week low is Rs 1,321.40.

Is POLYMED a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for POLYMED price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 4.8% CAGR), Base (12.0% CAGR), and Bull (optimistic at 33.1% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.